Bilavel-M Tablet

Overview Bilavel-M Tablet

Aller-Duo tablets combine two active ingredients to manage diverse allergic reactions. This medication alleviates inflammation (characterized by redness, soreness, warmth, and swelling), itching, and skin eruptions by inhibiting specific body chemicals. Aller-Duo can be administered with or without food. Dosage is condition-specific and should strictly adhere to your physician's instructions. Use may be intermittent (symptom-based) or continuous, as directed. Premature discontinuation may result in symptom recurrence. While generally well-tolerated, report any adverse effects to your doctor immediately. Prior to initiating treatment, disclose any liver, kidney, or heart conditions to ensure suitability. Pregnant or lactating individuals should seek medical counsel before use.

Uses of Bilavel-M Tablet

Managing Allergic Reactions

Major Benefits of Bilavel-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Bilavel-M Tablets can be administered with or without food, though consistent timing is recommended.

Common Side effects of Bilavel-M Tablet:

• Limited data available

How to use Bilavel-M Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bilavel-M Tablets can be consumed with or without food, though consistent timing is recommended.

How Bilavel-M Tablet works:

Bilastine and Montelukast, the active components of Bilavel-M tablets, offer combined allergy and asthma relief. Bilastine, an antihistamine, counteracts allergy symptoms like itching, swelling, and skin rashes by inhibiting histamine's action. Simultaneously, Montelukast's leukotriene-blocking mechanism reduces airway inflammation, thus managing asthma and alleviating allergic reactions.

What if you forget to take Bilavel-M Tablet :

NA